Clinical Trial Update: Hepatic Arterial Infusion Chemotherapy Combined With Sintilimab and Regorafenib as Adjuvant Therapy for Colorectal Liver Metastasis Patients With a High Risk of Recurrent: a Single-arm, Phase II Study [Phase 2]

View source ↗

Summary

A single-arm Phase II trial evaluating hepatic arterial infusion chemotherapy combined with sintilimab and regorafenib as adjuvant therapy for colorectal liver …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Liver Metastasis

Drugs mentioned

• Regorafenib (regorafenib)
• Sintilimab (sintilimab)

Snippet

Sponsor: Fudan University | Conditions: Colorectal Liver Metastasis | Phase 2 | Status: UNKNOWN